Employer coverage for weight-loss drugs rises sharply, survey finds

By Amina Niasse NEW YORK (Reuters) - About one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes management and weight loss, up from last year, according to a survey of global employers released on Thursday ...

Related Keywords

Canada ,United States ,Americans ,Amina Niasse ,Caroline Humer ,Eli Lilly Zepbound ,Novo Nordisk Wegovy ,Morgan Stanley ,International Foundation Of Employee Benefit ,Reuters ,International Foundation ,Employee Benefit ,Novo Nordisk ,Eli Lilly ,Rod Nickel ,